July 13, 2011
Shire LLC et al v. Mylan Pharmaceuticals, Inc. et al
Case Number:
1:11-cv-03414
Court:
Nature of Suit:
Judge:
Firms
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
July 15, 2011
Shire Targets Mylan In Latest Suit Over Generic Vyvanse
Shire PLC sued Mylan Inc. on Thursday in New York over a planned generic version of the attention deficit hyperactivity disorder treatment Vyvanse, marking the company's latest effort to protect the market for its top selling product.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
View the parties now
Already a subscriber? Click here to login